Airway Inflammation, Symptoms and Lung Function in COPD

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

July 31, 2011

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

COPD treatment

Patients, will be asked to continue their previous medication (GOLD guidelines) during the study. No interventional change in COPD treatment will be performed during the study.

Trial Locations (1)

44121

Research Centre on Asthma and COPD - Department of Clinical and Experimental Medicine - Section of Respiratory Disease - University of Ferrara, Ferrara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Università degli Studi di Ferrara

OTHER